Bioinformatic/Consulting

• RNA-targeted drug market 

• Therapeutic avenue delineation

• Target interactions and targetability

• Reverse translational models

• Optional RNA compatibility and/or solvation solutions

  • Custom selection criteria

(synthesizability/specificity/bioavailability)

Precision interferometry for processive endoribonucleases

• HTS SPR

• HTS Cleavage UV/Vis kinetics also available

  • HTS phenotypic screen in vivo

• Competitive costing

• Angiogenic model optimized

•  Model design services available